Biocartis Company

Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexed detection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland.

Headquarters: Lausanne, Vaud, Switzerland
Funding Status: IPO
Employee Number: 201-500
Investment Stage: N/A
Number Of Exists: N/A
Technology: Personalized Medicine
Investor Type: N/A
Founded Date: 2007
Industry: P3 Medicine